il-2 expressing salmonella typhimurium
Biologicalexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2010 (NCT01099631)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Salmonella typhiImmunity, active
Salmonella typhi immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- il-2 expressing salmonella typhimurium
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01099631 | Phase 1 | Apr 1, 2010 | University of Minnesota |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Minnesota | Academic/Hospital | 1 | 1 | 1 | 2010 |
1 organizations
Page 1 / 1